Speaking Engagements
 
Email Page
Demonstrating Biosimilarity: Guidance from the FDA
June 5, 2014

Axinn Counsel Stacie Ropka presented, "Demonstrating Biosimilarity: Guidance from the FDA," at the American Conference Institute's fifth annual Summit on Biosimilars.